These two stocks have been quietly making strides and could be long-term winners.
Canopy Growth stock has surged over 100% in 2024. Despite its recent gains, CGC stock remains a high-risk bet, due to its weak fundamentals and negative profit margins.
Growth stocks such as Viking Therapeutics, Cresco Labs, and Alphatec Holdings continue to trade at a significant discount to analysts' consensus price target estimates.
These three passive income stocks offer attractive dividend yields.
The U.S. cannabis market could be on the cusp of a critical growth catalyst, presenting ripe investment opportunities for those ready to navigate its unique risks.
Cresco Labs is an underrated and undervalued pot stock that cannabis investors shouldn't overlook.
Are these cannabis stocks worth investing in today?
Despite lingering regulatory challenges, the cannabis market is well-positioned for a steady expansion. Penny stock Cresco's solid financials and growth potential have won over analysts, while Tilray failed...
While AI stocks are the center of attention right now, many other growth stocks in various industries are going unnoticed. These stocks may benefit investors in the long run.
If you wait until there's movement on marijuana reform to buy these stocks, you could miss out on some incredible gains.